Page 5 - Amrit Mula News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amrit mula. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amrit Mula Today - Breaking & Trending Today

Exclusive: U.S. opens criminal probe into alleged lapses at Eli Lilly plant - sources


Exclusive: U.S. opens criminal probe into alleged lapses at Eli Lilly plant - sources
By Marisa Taylor, Mike Spector and Dan Levine
Reuters
(Reuters) - The U.S. Justice Department has launched a criminal investigation into Eli Lilly and Co focused on alleged manufacturing irregularities and records tampering at a factory in Branchburg, New Jersey, that produces the pharmaceutical giant s COVID-19 therapy and other drugs, three people familiar with the matter said.
The probe represents a significant escalation of the government scrutiny on Lilly. The pharmaceutical company, one of the world s largest, has been under examination for more than a year by the U.S. Food and Drug Administration over alleged manufacturing and records violations at the Branchburg factory. ....

New York , United States , New Jersey , San Francisco , Lydia Wible , Michele Gershberg , Eli Lilly , Gerald Masoudi , Mike Spector , Marisa Taylor , Julie Marquis , Steven Lynn , Dan Levine , Drug Administration , Justice Department , Us Justice Department , Office Of Manufacturing , Federal Bureau Of Investigation , Covington Burling , Bureau Of Investigation , Federal Bureau , Product Quality , Action Indicated , Amrit Mula , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் ,

EXCLUSIVE Lilly hit by staff accusations, FDA scrutiny at COVID drug factories


Healthcare & PharmaceuticalsEXCLUSIVE Lilly hit by staff accusations, FDA scrutiny at COVID drug factories
Marisa TaylorDan Levine
9 minute read
An Eli Lilly and Company pharmaceutical manufacturing plant is pictured at 50 ImClone Drive in Branchburg, New Jersey, March 5, 2021. REUTERS/Mike Segar
Eli Lilly & Co (LLY.N) employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker’s COVID-19 treatment, according to an internal Lilly complaint and a source familiar with the matter.
The unsigned report, filed April 8 in Lilly’s confidential employee complaint system and reviewed by Reuters, is the latest sign of manufacturing problems at the drug giant. The complaint asserts that the executive, a top quality official at the company’s factory in Branchburg, New Jersey, rewrote findings by Lilly technical experts at ....

United States , New Jersey , Southern Methodist University , Lydia Wible , Leanne Hickman , David Ricks , Kathryn Beiser , Nathan Cortez , Steven Lynn , Thomson Reuters Trust Principles , Us Department Of Health , Human Services , Drug Administration , Eli Lilly Co , Office Of Manufacturing , Eli Lilly , Chief Executive Officer David Ricks , Amrit Mula , Action Indicated , Product Quality , Thomson Reuters Trust , Co Vid , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜெர்சி , தெற்கு முறை பல்கலைக்கழகம் , ஒல்லியான ஹிக்மேன் ,

Exclusive: Lilly hit by staff accusations, FDA scrutiny at COVID drug factories


Exclusive: Lilly hit by staff accusations, FDA scrutiny at COVID drug factories
Reuters
3 hrs ago
By Dan Levine and Marisa Taylor
© Reuters/MIKE SEGAR
FILE PHOTO: FILE PHOTO: FILE PHOTO: An Eli Lilly and Co pharmaceutical manufacturing plant is pictured in Branchburg, New Jersey
By Dan Levine and Marisa Taylor
Popular Searches
(Reuters) - Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker’s COVID-19 treatment, according to an internal Lilly complaint and a source familiar with the matter. ....

United States , New Jersey , Southern Methodist University , San Francisco , Lydia Wible , Michele Gershberg , Nathan Cortez , Leanne Hickman , Kathryn Beiser , David Ricks , Marisa Taylor , Julie Marquis , Dan Levine , Steven Lynn , Us Department Of Health , Human Services , Drug Administration , Eli Lilly , Office Of Manufacturing , Eli Lilly Co , Chief Executive Officer David Ricks , Amrit Mula , Action Indicated , Product Quality , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜெர்சி ,

RPT-EXCLUSIVE-Lilly hit by staff accusations, FDA scrutiny at COVID drug factories


RPT-EXCLUSIVE-Lilly hit by staff accusations, FDA scrutiny at COVID drug factories
Reuters
3 hrs ago
(Repeats to additional subscribers with no changes to the text)
By Dan Levine and Marisa Taylor
May 5 (Reuters) - Eli Lilly & Co employees have accused a factory executive of altering documents required by government regulators in an effort to downplay serious quality control problems at the U.S. plant producing the drugmaker’s COVID-19 treatment, according to an internal Lilly complaint and a source familiar with the matter.
The unsigned report, filed April 8 in Lilly’s confidential employee complaint system and reviewed by Reuters, is the latest sign of manufacturing problems at the drug giant. The complaint asserts that the executive, a top quality official at the company’s factory in Branchburg, New Jersey, rewrote findings by Lilly technical experts at the plant, which has been under investigation by the U.S. Food and Drug Administration, to mak ....

United States , New Jersey , Southern Methodist University , San Francisco , Lydia Wible , Michele Gershberg , Nathan Cortez , Leanne Hickman , Kathryn Beiser , David Ricks , Marisa Taylor , Julie Marquis , Dan Levine , Steven Lynn , Us Department Of Health , Human Services , Drug Administration , Office Of Manufacturing , Eli Lilly Co , Chief Executive Officer David Ricks , Amrit Mula , Action Indicated , Product Quality , ஒன்றுபட்டது மாநிலங்களில் , புதியது ஜெர்சி , தெற்கு முறை பல்கலைக்கழகம் ,